Up Therapeutics
PrivateTotal Funding Raised
$2.5M
Company Overview
Up Therapeutics is a biotechnology company that develops small molecule Rpn13 inhibitors for the treatment of various cancers, including solid tumors.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Up Therapeutics Comparables
Compare Up Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| SHY Therapeutics | 82% | |
| QLi5 Therapeutics GmbH | 77% | |
| Ubiquigent Limited | 63% |
Up Therapeutics Funding Rounds
Historical fundraising activity
Up Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Cancer Institute | Grant |
| National Institutes of Health (NIH) | Grant |
Up Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Up Therapeutics's valuation, stock price, and market status.
Is Up Therapeutics a public or private company?
Up Therapeutics is a private company.
What is the current stock price of Up Therapeutics?
Up Therapeutics is a private company, so its shares have no public market price. Caplight tracks Up Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Up Therapeutics worth (valuation)?
Valuation information for Up Therapeutics is not publicly available.
Can I buy Up Therapeutics stock?
Up Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Up Therapeutics's last funding round?
Funding round information for Up Therapeutics is not publicly available.
Who are the main investors in Up Therapeutics?
Key investors in Up Therapeutics include National Cancer Institute, National Institutes of Health (NIH).
Will Up Therapeutics IPO soon?
No public IPO plans have been announced for Up Therapeutics.
How can I track Up Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Up Therapeutics's shares on secondary markets.